BioAdaptives Inc (BDPT)

[Digby1]

DR. TED - CEO - zero credibility issues
Dr. Edward E. Jacobs, Jr. (Dr. Ted), a graduate of Princeton University and Harvard Medical school, is a biotechnology consultant with over 25 years of experience in biopharmaceutical and medical device development, as well as 35 years of teaching and direct patient care.

Dr. Ted has participated in drug development processes, from discovery through animal and human studies, including regulatory support for FDA, and international regulatory affairs, strategic planning,
and investor relations.

Dr. Ted has extensive clinical operations experience, having executed more than 15 human trials in the U.S., Europe, and South Africa. He has also served as a Medical Monitor and Liaison for clinical investigators involved with international trials, with responsibility for regulatory compliance.

In his research, Dr. Ted has made original observations in the field of artificial blood, tissue oxygenation therapy, and water modification. His current focus is on natural products for human and animal use, anti-aging strategies, and primitive cell biology. He is an author of more than 40 scientific publications, and is the holder of 4 patents.